[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Amarillo_Slim1 Amarillo Slim
Amarillo Slim posts on X about $avbp, $100sh, $15bn, $txn the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX +3,509%
- X Month XXXXXXX +285%
- X Months XXXXXXX +1,734%
- X Year XXXXXXX +7,811%
Mentions: X #
- X Week XX +111%
- X Month XX +113%
- X Months XX +355%
- X Year XX +638%
Followers: XXXXXX #
- X Week XXXXXX +0.62%
- X Month XXXXXX +6.50%
- X Months XXXXXX +12%
- X Year XXXXXX +10%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks XXXXX% technology brands XXXX%
Social topic influence $avbp 15.79%, $100sh 10.53%, $15bn 10.53%, $txn 5.26%, $qbts 5.26%, $ionq 5.26%, $10m 5.26%, qbts 5.26%, approved 5.26%, should be XXXX%
Top accounts mentioned or mentioned by @jonathanross321 @ronniewiess @274kaum @batmongoose @waterworldcapi1 @dynamicmoats @wolfejosh @benbstwits @pgainz96934 @optionenjoyer @ahart1974 @coinflipcap
Top assets mentioned Texas Instruments (TXN) D-Wave Quantum Inc. (QBTS) IonQ, Inc. (IONQ) NVIDIA Corp. (NVDA)
Top Social Posts #
Top posts by engagements in the last XX hours
"$TXN LAST CUT WE PROMISE THIS TIME"
X Link @Amarillo_Slim1 2025-10-21T20:50Z 11.3K followers, 2568 engagements
"Why would $QBTS (a Canadian company) get US govt funding Idiots should think before they believe nonsensical pump and dump headlines"
X Link @Amarillo_Slim1 2025-10-23T13:52Z 11.3K followers, 33.2K engagements
"$AVBP is worth $100/sh. It is easily the best asymmetry in the biotech market"
X Link @Amarillo_Slim1 2025-10-23T19:47Z 11.3K followers, 16.1K engagements
"Firmo has patent life out to 2042 and given the patient population it will monopolize 1L Exon20 and PACC as FDA trial design requires TKI-naive patients to be enrolled in study. Therefore once approved no competitors will be able to even enroll a study"
X Link @Amarillo_Slim1 2025-10-23T23:24Z 11.3K followers, XXX engagements
"Pricing should be in-line with Tagrisso ($300k per year) which sizes the US Exon20 market opportunity at $900m and PACC market at $1.5bn. No real treatment options and high ORR/duration means $AVBP will take a large majority of the market"
X Link @Amarillo_Slim1 2025-10-23T23:24Z 11.3K followers, XXX engagements
"$AVBP lead asset firmonertinib is a best in class TKI for EGFR non-small cell lung cancer mutations. De-risked asset with incredible data to date. No safety issues. X indications in Exon-20 and PACC in pivotal p3. Major catalyst in early Q1 with Exon-20 data readout. $1.5bn drug"
X Link @Amarillo_Slim1 2025-10-23T23:24Z 11.3K followers, 9340 engagements
"Jensen making fun of everyone lol"
X Link @Amarillo_Slim1 2025-10-28T15:34Z 11.3K followers, 34.1K engagements